Obstructive sleep apnea syndrome and cardiovascular diseases;Sindrome dell'apnea ostruttiva notturna e malattie cardiovascolari

Giornale Italiano di Cardiologia

Volumn 9, Issue 7, 2008, Pages 472-481

  Bentivoglio, Maurizio ^a   Bergamini, Eva ^a   Fabbri, Marta ^a   Andreoli, Chiara ^a   Bartolini, Claudia ^a   Cosmi, Deborah ^a   Capasso, Vincenzo ^a   Bottini, Paolo ^b   Ambrosio, Giuseppe ^a,c  

^a SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^b Ospedale di Umbertide (PG)   (Italy)

^c Ospedale Silvestrini   (Italy)

Author keywords

Cardiovascular risk; Continuous positive airway pressure; Obstructive sleep apnea syndrome; Sleep apnea

Indexed keywords

CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; RESPIRATORY TRACT DISEASE; REVIEW; SLEEP APNEA SYNDROME; SYMPATHETIC TONE;

ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYSOMNOGRAPHY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 48249134359     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Gastaut H, Tassinari CA, Duron B. Polygraphic study of diurnal and nocturnal (hypnic and respiratory) episodal manifestations of Pickwick syndrome. Rev Neurol (Paris) 1965; 112: 568-79.
2. Jung R, Kuhlo W. Neurophysiological studies of abnormal night sleep and the Pickwickian syndrome. Prog Brain Res 1965; 18: 140-59.
3. Lugaresi E, Coccagna G, Mantovani M, Cirignotta F, Ambrosetto G, Baturic P. Hypersomnia with periodic breathing: periodic apneas and alveolar hypoventilation during sleep. Bull Physiopathol Respir (Nancy) 1972; 8: 1103-13.
4. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med 1976; 27: 465-84.
5. Bradley TD, Floras JS. Sleep apnea and heart failure. Part I: Obstructive sleep apnea. Circulation 2003; 107: 1671-8.
6. Remmers JE, deGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978; 44: 931-8.
7. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-89.
8. Partinem M, Hublin CH. Epidemiology of sleep disorders. In: Kringer MH, Roth TH, Dement W, eds. Principles and practice of sleep medicine. 3rd edition. Philadelphia, PA: WB Saunders, 2000: 558-79.
9. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.
10. Redline S. Epidemiology of sleep-disordered breathing. Semin Respir Crit Care Med 1998; 19: 113-22.
11. Dexter DD, Dovre EJ. Obstructive sleep apnea due to endogenous testosterone production in a woman. Mayo Clin Proc 1998; 73: 246-8.
12. Kripke DF, Ancoli-Israel S. Epidemiology of sleep apnoea among the aged: is sleep apnoea a fatal disordered? In: Guilleminault C, Lugaresi E, eds. Sleep/wake disorder: natural, history, epidemiology and long-term evolution. New York, NY: Raven Press, 1983: 137-42.
13. Bottini P, Redolfi S, Dottorini ML, Tantucci C. Autonomic neuropathy increases the risk of obstructive sleep apnea in obese diabetics. Respiration, in press.
14. Fogel RB, Malhotra A, White DP. Pathophysiology of obstructive sleep apnoea/hypopnoea syndrome. Thorax 2004; 59: 159-63.
15. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19-25.
16. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320: 479-82.
17. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990; 336: 261-4.
18. Dyken ME, Somers VK, Yamada T, Ren ZY, Zimmerman MB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996; 27: 401-7.
19. Lanfranchi P, Somers VK. Ostructive sleep apnea and vascular disease. Respir Res 2001; 2: 315-9.
20. Somers VK, Mark AL, Zavala DC, Abboud FM. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol 1989; 67: 2095-100.
21. Somers VK, Mark AL, Zavala DC, Abboud FM. Contrasting effects of hypoxia and hypocapnia on ventilation and sympathetic activity in humans. J Appl Physiol 1989; 67: 2101-6.
22. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-904.
23. Guilleminault C, Motta J, Mihm F, Melvin K. Obstructive sleep apnea and cardiac index. Chest 1986; 89: 331-4.
24. Katzenberg C, Olajos M, Morkin E, Goldman S. Effects of changes in airway pressure on the left ventricle and left atrium of dogs. Cardiovasc Res 1986; 20: 853-62.
25. Buda AJ, Pinsky MR, Ingles NB Jr, Daughters GT 2nd, Stinson EB, Alderman EL. Effect of intrathoracic pressure on left ventricular performance. N Engl J Med 1979; 301: 453-9.
26. Chaudhary BA, Ferguson DS, Speir WA Jr. Pulmonary edema as a presenting feature of sleep apnea syndrome. Chest 1982; 82: 122-4.
27. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84.
28. Suzuki YJ, Jain V, Park AM, Day RM. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 2006; 40: 1683-92.
29. Ambrosio G, Zweier JL, Duilio C, et al. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem 1993; 268: 18532-41.
30. Ambrosio G, Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J 1999; 138 (2 Pt 2): S69-S75.
31. Ambrosio G, Flaherty JT, Duilio C, et al. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 1991; 87: 2056-66.
32. Terada LS, Guidot DM, Leff JA, et all. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proc Natl Acad Sci USA 1992; 89: 3362-6.
33. Ambrosio G, Zweier JL, Flaherty JT. The relationship between oxygen radical generation and impairment of myocardial energy metabolism following post-ischemic reperfusion. J Mol Cell Cardiol 1991; 23: 1359-74.
34. Ambrosio G, Zweier JL, Jacobus WE, Weisfeldt ML, Flaherty JT. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation 1987; 76: 906-15.
35. Dean RT, Wilcox I. Possible atherogenic effects of hypoxia during obstructive sleep apnea. Sleep 1993; 16 (8 Suppl): S15-S22.
36. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95.
37. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-63.
38. Schulz R, Seeger W, Grimminger F. Serum nitrite/nitrate levels in obstructive sleep apnea. Am J Respir Crit Care Med 2001; 164 (10 Pt 1): 1997-8.
39. Schulz R, Schmidt D, Blum A, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000; 55: 1046-51.
40. Haight JS, Djupesland PG. Nitric oxide (NO) and obstructive sleep apnea (OSA). Sleep Breath 2003; 7: 53-62.
41. Dart RA, Gregoire JR, Gutterman DD, Woolf SH. The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing. Chest 2003; 123: 244-60.
42. Baldwin DR, Kolbe J, Troy K, et al. Comparative clinical and physiological features of Maori, Pacific Islanders and Europeans with sleep related breathing disorders. Respirology 1998; 3: 253-60.
43. Somers V, Fletcher E. Mechanisms of hypertension in obstructive sleep apnea. In: Pack A, ed, Sleep apnea: pathogenesis, diagnosis and treatment. New York, NY: Marcel Dekker, 2002: 353-76.
44. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997; 99: 106-9.
45. Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001; 164: 2147-65.
46. Hoffstein V, Mateika J. Evening-to-morning blood pressure variations in snoring patients with and without obstructive sleep apnea. Chest 1992; 101: 379-84.
47. Loredo JS, Ancoli-Israel S, Dimsdale JE. Sleep quality and blood pressure dipping in obstructive sleep apnea. Am J Hypertens 2001; 14 (9 Pt 1): 887-92.
48. Portaluppi F, Provini F, Cortelli P, et al. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens 1997; 15: 1227-33.
49. Verdecchia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 91: 528-36.
50. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnea. J Hypertens 1990; 8: 941-6.
51. Noda A, Okada T, Yasuma F, Nakashima N, Yokota M. Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest 1995; 107: 1538-44.
52. Dursunoglu D, Dursunoglu N, Evrengul H, et al. Impact of obstructive sleep apnoea on left ventricular mass and global function. Eur Respir J 2005; 26: 283-8.
53. Hedner J, Ejnell H, Sellgren J, Hedner T, Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenic importance for the development of hypertension? J Hypertens Suppl 1988; 6: S529-S531.
54. Verdecchia P, Porcellati C, Reboldi G, et al. Left ventricular hypertrophy as an predictor of acute cerebrovascular events in essential hypertension. Circulation 2001; 104: 2039-44.
55. Morgan HE, Baker M Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation 1991; 83: 13-25.
56. Frohlich ED. The heart in hypertension: a 1991 overview. Hypertension 1991; 18 (5 Suppl): III62-III68.
57. Guilleminault C, Abad VC. Obstructive sleep apnea syndromes. Med Clin North Am 2004; 88: 611-30.
58. Mehra R, Benjamin EJ, Shahar E, et al, for the Sleep Heart Health Study. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173: 910-6.
59. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005; 352: 1206-14.
60. Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998; 98: 1071-7.
61. Gillis AM, Stoohs R, Guilleminault C. Changes in the QT interval during obstructive sleep apnea. Sleep 1991; 14: 346-50.
62. Carlson JT, Hedner JA, Sellgren J, Elam M, Wallin BG. Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996; 154: 1490-6.
63. Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N, Somers VK. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 1999; 99: 1183-9.
64. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure, Am J Respir Crit Care Med 1999; 160: 1101-6.
65. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation 1998; 97: 2154-9.
66. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233-41.
67. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005; 112: 375-83.
68. Mooe T, Gullsby S, Rabben T, Eriksson P. Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery. Coron Artery Dis 1996; 7: 475-8.
69. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107: 2589-94.
70. Gami AS, Hodge DO, Herges RM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007; 49: 565-71.
71. Verdecchia P, Reboldi G, Gattobigio R, et al. Atrial fibrillation in hypertension: predictors and outcome. Hypertension 2003; 41: 218-23.
72. Tsang TS, Gersh BJ, Appleton CP, et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed non-valvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002; 40: 1636-44.
73. Hall MJ, Ando S, Floras JS, Bradley TD. Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. J Appl Physiol 1998; 85: 1476-84.
74. Tkacova R, Rankin F, Fitzgerald FS, Floras JS, Bradley TD. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 1998; 98: 2269-75.
75. Floras JS, Bradley TD. Treating obstructive sleep apnea: is there more to the story than 2 millimeters of mercury? Hypertension 2007; 50: 289-91.
76. Roche F, Xuong AN, Court-Fortune I, et al. Relationship among the severity of sleep apnea syndrome, cardiac arrhythmias, and autonomic imbalance. Pacing Clin Electrophysiol 2003; 26: 669-77.
77. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462-4.
78. Oksenberg A, Silverberg DS, Arons E, Radwan H. Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic, and multiple sleep latency test data. Chest 1997; 112: 629-39.
79. Taasan VC, Block AJ, Boysen PG, Wynne JW. Alcohol increases sleep apnea and oxygen desaturation in asymptomatic men. Am J Med 1981; 71: 240-5.
80. Smith PL, Gold AR, Meyers DA, Haponik EF, Bleecker ER. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985; 103 (6 Pt 1): 850-5.
81. Farre R, Hernandez L, Montserrat JM, Rotger M, Ballester E, Navajas D. Sham continuous positive airway pressure for placebo-controlled studies in sleep apnoea. Lancet 1999; 353: 1154.
82. Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999; 353: 2100-5.
83. Basner RC. Continuous positive airway pressure for obstructive sleep apnea. N Eng J Med 2007; 356: 1751-8.
84. Meurice JC, Marc I, Series F. Efficacy of auto-CPAP in the treatment of obstructive sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1996; 153: 794-8.
85. D'Ortho MP, Grillier-Lanoir V, Levy P, et al. Constant vs automatic continuous positive airway pressure therapy: home evaluation. Chest 2000; 118: 1010-7.
86. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68-73.
87. Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007; 50: 417-23.
88. Campos-Rodriguez F, Perez-Ronchel J, Grilo-Reina A, Lima-Alvarez J, Benitez MA, Almeida-Gonzalez C. Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest 2007; 132: 1847-52.
89. Malone S, Liu PP, Holloway R, Rutherford R, Xie A, Bradley TD. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 1991; 338: 1480-4.
90. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007; 49: 1625-31.
91. Naughton MT, Rahman MA, Hara K, Floras JS, Bradley TD. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 1995; 91: 1725-31.
92. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993; 328: 303-7.
93. Butler GC, Naughton MT, Rahman MA, Bradley TD, Floras JS. Continuous positive airway pressure increases heart rate variability in congestive heart failure. J Am Coll Cardiol 1995; 25: 672-9.
94. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007; 176: 706-12.
95. Flemons WW. Obstructive sleep apnea. N Engl J Med 2002; 347: 498-504.